Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion

Business

A Johnson & Johnson building is shown in Irvine, California.

Mike Blake | Reuters

Johnson & Johnson announced Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine for the U.S. in a deal totaling more than $1 billion. 

The deal gives the U.S. the option to order an additional 200 million doses, the company said. 

“We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Paul Stoffels, chief science officer at Johnson & Johnson, in a statement. 

This is developing news. Please check back later for updates. 

Products You May Like

Articles You May Like

ChatGPT blocked 250,000 image generations of presidential candidates
Erin Krakow Reveals ‘Full Circle’ Nod to ‘When Calls the Heart’ in ‘Santa Tell Me’
photoacoustic device detects disease without taking a single drop of blood – Physics World
Watch Guns N’ Roses’ Duff McKagan and The Wallflowers’ Jakob Dylan cover David Bowie’s ‘Heroes’
China urges U.S. cooperation as Trump trade threat looms